Keeps Biopharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	163,436	97,681	119,991	127,866	235,610	309,093
Market Cap Growth	35.78%	-18.59%	-6.16%	-45.73%	-23.77%	428.37%
Enterprise Value	209,429	122,355	160,512	124,281	215,414	294,582
Last Close Price	8140.00	5210.00	6400.00	6820.00	13100.00	20150.00
PE Ratio	-	87.73	30.53	-	-	-
Forward PE	-	3.21	3.21	3.21	3.21	3.21
PS Ratio	1.04	0.77	1.30	8.75	55.30	20.31
PB Ratio	1.82	1.55	2.05	2.45	3.87	6.07
P/TBV Ratio	5.74	8.76	4.50	2.45	3.92	6.28
P/OCF Ratio	-	20.31	-	-	-	-
EV/Sales Ratio	1.33	0.96	1.74	8.50	50.56	19.36
EV/EBITDA Ratio	-	13.89	35.65	-	-	1355.37
EV/EBIT Ratio	-	19.65	52.45	-	-	-
Debt / Equity Ratio	0.79	0.88	0.83	0.55	0.45	0.41
Debt / EBITDA Ratio	29.15	6.33	10.73	-	-	95.42
Net Debt / Equity Ratio	0.35	0.52	0.64	0.07	-0.22	-0.21
Net Debt / EBITDA Ratio	12.96	3.72	8.31	-0.46	1.16	-50.45
Net Debt / FCF Ratio	-2.03	-18.32	-35.68	-3.76	1.57	3.94
Asset Turnover	0.88	0.90	0.91	0.16	0.05	0.26
Inventory Turnover	7.19	8.57	22.90	7.05	4.01	6.10
Quick Ratio	0.80	0.47	0.40	0.99	1.59	1.67
Current Ratio	1.55	0.83	0.84	1.35	2.10	2.29
Return on Equity (ROE)	0.30%	2.65%	6.25%	-21.28%	-29.03%	-6.27%
Return on Assets (ROA)	-0.26%	2.76%	1.89%	-6.23%	-9.03%	-0.42%
Return on Invested Capital (ROIC)	-0.64%	3.10%	2.60%	-17.23%	-28.11%	-1.21%
Return on Capital Employed (ROCE)	-0.50%	7.80%	5.00%	-16.70%	-19.50%	-0.70%
Earnings Yield	-0.02%	1.14%	3.28%	-8.90%	-6.50%	-0.78%
FCF Yield	-9.55%	-1.83%	-0.87%	-0.75%	-3.60%	-0.90%
Buyback Yield / Dilution	-2.50%	-0.38%	-0.40%	-8.22%	-18.22%	-14.07%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.